{"id":41856,"date":"2019-04-03T18:24:18","date_gmt":"2019-04-03T16:24:18","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=41856"},"modified":"2019-05-13T13:29:56","modified_gmt":"2019-05-13T11:29:56","slug":"farmaci-usa-nel-2018-3-della-spesa-in-pubblicita-pfizer-prima-inserzionista","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/farmaci-usa-nel-2018-3-della-spesa-in-pubblicita-pfizer-prima-inserzionista\/","title":{"rendered":"Drugs, USA: +3% of advertising spending in 2018, Pfizer first advertiser"},"content":{"rendered":"<p class=\"pw-hidden-cp\"><em><span style=\"font-size: 18px;\">Pharmaceutical industry spending on advertising increased 3% last year in the United States to a record $6.4 billion, according to Nielsen data<\/span><\/em><\/p>\n<div class=\"pw-hidden-cp\">\n<p><a href=\"http:\/\/www.meteoweb.eu\/2019\/04\/farmaci-usa-nel-2018-3-della-spesa-in-pubblicita\/1245579\/\" target=\"_blank\" rel=\"noopener\">MeteoWeb \u2013 3 April 2019 \u2013 edited by Antonella Petris<\/a><\/p>\n<div class=\"pw-hidden-cp\">\n<p><a href=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2019\/04\/pubblicita\u0300-media.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-41859 alignright\" src=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2019\/04\/pubblicita\u0300-media-1024x768.jpg\" alt=\"\" width=\"455\" height=\"341\" srcset=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2019\/04\/pubblicita\u0300-media-1024x768.jpg 1024w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2019\/04\/pubblicita\u0300-media-300x225.jpg 300w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2019\/04\/pubblicita\u0300-media-768x576.jpg 768w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2019\/04\/pubblicita\u0300-media-1536x1152.jpg 1536w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2019\/04\/pubblicita\u0300-media-2048x1536.jpg 2048w\" sizes=\"auto, (max-width: 455px) 100vw, 455px\" \/><\/a>Pharmaceutical industry spending on advertising increased 3% last year in the United States to a record $6.4 billion, according to Nielsen data. The top five advertisers are Pfizer, AbbVie, Eli Lilly, Amgen and AstraZeneca. Pfizer took the top spot with $1.1 billion in ad spend, double the amount incurred by second-place finisher, Abbvie. The majority of this amount went to television commercials, amounting to $5.1 billion, about 80% of the total.<\/p>\n<p>Spending on advertising on the small screen - reports &#039;MedicalMarketingMedia&#039; - is followed in size by that for promotion in magazines, equal to 1 billion dollars, and by digital one at 197 million. This last item decreased by 18% compared to the previous year, 2017, while television advertising expenditure increased by 8.5%. Newspaper announcements, after a slight increase recorded in 2017, showed a sharp decline, equal to 38%.<\/p>\n<p>Surprisingly, industry spending on film advertising tripled in 2018 to $11 million, surpassing that for outdoor ads. Eli Lilly&#039;s diabetes drug Trulicity* is the most advertised brand (moreover, for some time, with commercials that also refer to websites that indicate the prices of the treatment): 243 million dollars spent by the Indianapolis giant in 2018. Followed by the anti-smoking Chantix* by Pfizer, the anti-psoriasis Otezla* by Celgene, the immunotherapy Keytruda* by Msd and the anti-arthritis Xeljanz* also by Pfizer.<\/p>\n<p>Related news: <a href=\"https:\/\/www.mmm-online.com\/home\/channel\/nielsen-pfizer-tops-list-of-biggest-pharma-advertisers-in-2018\/\" target=\"_blank\" rel=\"noopener\">Nielsen: Pfizer tops list of biggest pharma advertisers in 2018<\/a><\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>La spesa sostenuta dall&#8217;industria farmaceutica per la pubblicit\u00e0 \u00e8 aumentata del 3% lo scorso anno negli Stati Uniti, raggiungendo la cifra record di 6,4 miliardi di dollari, secondo dati Nielsen MeteoWeb &#8211; 3 aprile 2019 &#8211; a cura di Antonella Petris La spesa sostenuta dall\u2019industria farmaceutica per la pubblicit\u00e0 \u00e8 aumentata del 3% lo scorso &hellip;<\/p>","protected":false},"author":4,"featured_media":41857,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-41856","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/41856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=41856"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/41856\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/41857"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=41856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=41856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=41856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}